Home
My Account
About Us
Forum
Contact us
الواجهة العربية
epharmaweb.com
Medical News Medical News
Aricles Articles
Events Events
Guidelines Guidelines
Videos Library Videos Library
Diseases Diseases
Follow us : facebook twitter Digg Linkedin Boxiz
Newsletter

Please select the categories you are intersted in:
News Articles Guidelines Events Videos Journals' abstracts

Latest Subscribers
Advanced Search »



Apatef

Main

You must sign in to use this servcie


Feedback - Please use the form below to send your query or comment

You must sign in to use this servcie

Username:
Password:

Info

Indications:

Treatment of infections of urinary tract, lower respiratory tract, skin and skin structures, bone and joint; treatment of gynecological infections; treatment of intra-abdominal infections caused by susceptible strains of specific microorganisms; perioperative prophylaxis. Concomitant antibiotic therapy If cefotetan and an aminoglycoside are to be used concomitantly, carefully monitor renal function, especially if higher dosages of the aminoglycoside are to be administered or if therapy is to be prolonged, because of the potential nephrotoxicity and ototoxicity of aminoglycosides

Contraindications:

Hypersensitivity to cephalosporins.

Adverse reactions:

GI Nausea; vomiting; diarrhea; anorexia; abdominal pain or cramps; flatulence; colitis, including pseudomembranous colitis. Genitourinary Pyuria; renal dysfunction; dysuria; reversible interstitial nephritis; hematuria; toxic nephropathy. Hematologic Eosinophilia; neutropenia; lymphocytosis; leukocytosis; thrombocytopenia; decreased platelet function; anemia; aplastic anemia; hemorrhage. Hepatic Hepatic dysfunction; abnormal LFT results. Miscellaneous Hypersensitivity, including Stevens-Johnson syndrome, erythema multiforme, toxic epidermal necrolysis; candidal overgrowth; serum sickness–like reactions (eg, skin rashes, polyarthritis; arthralgia, fever); phlebitis, thrombophlebitis, and pain at injection site.

Interactions:

Alcohol Acute alcohol intolerance (disulfiram-like reaction) may occur up to 3 days after last dose of cefotetan. Aminoglycosides Increased risk of nephrotoxicity. Anticoagulants, oral Increased anticoagulant effect; bleeding complications may occur. Incompatibility Aminoglycosides Do not add aminoglycosides to cefotetan solutions because inactivation of both drugs may result; administer at separate sites if concurrent therapy is indicated. Laboratory Test Interactions May cause false-positive urine glucose test results with Benedict’s solution, Fehling’s solution, or Clinitest tablets but not with enzyme-based tests (eg, Clinistix , Tes-tape ); false-positive test result for proteinuria with acid and denaturization-precipitation tests; false-positive direct Coombs ’ test results in certain patients (eg, those with azotemia); false elevations in urinary 17-ketosteroid values. High concentrations may interfere with creatinine concentrations measured by the Jaffe reaction, producing false results; do not analyze serum samples for creatinine if obtained within 2 hr of drug administration.

Warnings:

Monitor Coagulation abnormalities Monitor for coagulation abnormalities. Elevate prothrombin time or abnormal platelet count may occur. If bleeding occurs and PT is prolonged, vitamin K may be indicated. Response to therapy Monitor patient’s response to therapy. Notify health care provider if infection does not appear to improve or worsens. Side effects Monitor patient for GI, DERM, and general body side effects, and signs of superinfection. Inform health care provider if noted and significant. Immediately report severe diarrhea, diarrhea containing blood or pus, or severe abdominal cramping. Pregnancy Category B . Lactation Excreted in breast milk. Children Safety and efficacy in children not established. Hypersensitivity Reactions range from mild to life-threatening. Administer drug with caution to penicillin-sensitive patients because of possible cross-reactivity. Renal Function Use drug with caution in patients with renal impairment. Dosage adjustment based on renal function may be required. Superinfection May result in bacterial or fungal overgrowth of nonsusceptible microorganisms. Pseudomembranous colitis Consider in patients who develop diarrhea.

Form:

SOLUTION FOR INJECTION

Dosage and Administration

You must sign in to use this servcie

Technical Description

You must sign in to use this servcie






Forgot your password


sign up

Consultants Corner

Dr. Talal Sabouni

Dr. Talal Sabouni UROLOGY AND KIDNEY TRANSPLANT

Dr . Dirar Abboud

Dr . Dirar Abboud Hepatologist – Gastroenterologist

Dr. Hani Najjar

Dr. Hani Najjar Pediatrics, Neurology

Samir Moussa M.D.

Samir Moussa M.D. ENT Specialist

Dr. Tahsin Martini

Dr. Tahsin Martini Degree status: M.D. in Ophthalmology

Dr. Samer Al-Jneidy

Dr. Samer Al-Jneidy Pediatrician

Dr. Faisal Dibsi

Dr. Faisal Dibsi Specialist of Otolaryngology - Head and Neck Surgery

Yaser Habrawi , F.R.C.S.Ed

Yaser Habrawi , F.R.C.S.Ed Consultant Ophthalmologist
Poll

Which of the following you are mostly interested in?

Cancer Research
Mental Health
Heart Disease & Diabetes
Sexual Health
Obesity and Healthy Diets
Mother & Child Health

Disclaimer : This site does not endorse or recommend any medical treatment, pharmaceuticals or brand names. More Details